Skip to main content

Drug Safety Update

From:
Medicines and Healthcare products Regulatory Agency
Skip to results
  • Pioglitazone: risk of bladder cancer

    Use of pioglitazone is associated with a small increased risk of bladder cancer. Healthcare professionals should be aware of new warnings and precautions for use in at-risk patients

    • Therapeutic area: Endocrinology, diabetology and metabolism
    • Published:
  • Insulin combined with pioglitazone: risk of cardiac failure

    If pioglitazone is used in combination with insulin patients should be observed for signs and symptoms of heart failure, weight gain, and oedema.

    • Therapeutic area: Endocrinology, diabetology and metabolism
    • Published: